Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,044 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic significance of the albumin-to-globulin ratio for advanced urothelial carcinoma treated with pembrolizumab: a multicenter retrospective study.
Taguchi S, Kawai T, Nakagawa T, Nakamura Y, Kamei J, Obinata D, Yamaguchi K, Kaneko T, Kakutani S, Tokunaga M, Uemura Y, Sato Y, Fujimura T, Fukuhara H, Enomoto Y, Nishimatsu H, Takahashi S, Kume H. Taguchi S, et al. Among authors: tokunaga m. Sci Rep. 2021 Aug 2;11(1):15623. doi: 10.1038/s41598-021-95061-z. Sci Rep. 2021. PMID: 34341416 Free PMC article.
Impact of immune-related adverse events on the therapeutic efficacy of pembrolizumab in urothelial carcinoma: a multicenter retrospective study using time-dependent analysis.
Kawai T, Taguchi S, Nakagawa T, Kamei J, Nakamura Y, Obinata D, Yamaguchi K, Kaneko T, Kakutani S, Tokunaga M, Uemura Y, Sato Y, Enomoto Y, Nishimatsu H, Fujimura T, Fukuhara H, Takahashi S, Kume H. Kawai T, et al. Among authors: tokunaga m. J Immunother Cancer. 2022 Feb;10(2):e003965. doi: 10.1136/jitc-2021-003965. J Immunother Cancer. 2022. PMID: 35210308 Free PMC article.
Validation of a drug-based score in advanced urothelial carcinoma treated with pembrolizumab.
Taguchi S, Kawai T, Buti S, Bersanelli M, Uemura Y, Kishitani K, Miyakawa J, Sugimoto K, Nakamura Y, Niimi F, Kaneko T, Kamei J, Obinata D, Yamaguchi K, Kakutani S, Kanazawa K, Sugihara Y, Tokunaga M, Akiyama Y, Yamada Y, Sato Y, Yamada D, Enomoto Y, Nishimatsu H, Fujimura T, Fukuhara H, Nakagawa T, Takahashi S, Kume H. Taguchi S, et al. Among authors: tokunaga m. Immunotherapy. 2023 Aug;15(11):827-837. doi: 10.2217/imt-2023-0028. Epub 2023 May 16. Immunotherapy. 2023. PMID: 37191002
Improved survival in real-world patients with advanced urothelial carcinoma: A multicenter propensity score-matched cohort study comparing a period before the introduction of pembrolizumab (2003-2011) and a more recent period (2016-2020).
Taguchi S, Kawai T, Nakagawa T, Miyakawa J, Kishitani K, Sugimoto K, Nakamura Y, Kamei J, Obinata D, Yamaguchi K, Kaneko T, Yoshida K, Yamamoto S, Kakutani S, Kanazawa K, Sugihara Y, Tokunaga M, Matsumoto A, Uemura Y, Akiyama Y, Yamada Y, Sato Y, Yamada D, Enomoto Y, Nishimatsu H, Ishikawa A, Tanaka Y, Nagase Y, Fujimura T, Fukuhara H, Takahashi S, Kume H. Taguchi S, et al. Among authors: tokunaga m. Int J Urol. 2022 Dec;29(12):1462-1469. doi: 10.1111/iju.15014. Epub 2022 Aug 22. Int J Urol. 2022. PMID: 35996761 Free PMC article.
[A case of small intestinal endometriosis with bowel obstruction and perforation].
Kitamura K, Shinagawa K, Tokunaga M, Kobayashi S, Ueda A, Tokimitsu Y, Okada K, Maeda Y, Shibahara K, Yasuda I. Kitamura K, et al. Among authors: tokunaga m. Nihon Shokakibyo Gakkai Zasshi. 2024;121(5):400-406. doi: 10.11405/nisshoshi.121.400. Nihon Shokakibyo Gakkai Zasshi. 2024. PMID: 38735748 Japanese.
Novel reconstruction using pedicled ileocolic interposition with intrathoracic esophago-ileal anastomosis after distal esophagectomy for esophagogastric junction cancer: A report of two cases.
Fujiwara H, Shigeo H, Ogo T, Kawada K, Yamaguchi K, Sakano M, Keisuke O, Sato Y, Tanioka T, Tokunaga M, Kinugasa Y. Fujiwara H, et al. Among authors: tokunaga m. Asian J Endosc Surg. 2024 Jul;17(3):e13323. doi: 10.1111/ases.13323. Asian J Endosc Surg. 2024. PMID: 38735654
1,044 results